Search

everythinglearnresearchcommunity

for

Search:↓

Young men with hair loss may have a higher risk of insulin resistance and related health issues.

Lower 2D:4D ratio and older age increase the risk of severe hair loss in men.

Men with early-onset baldness may have a higher risk of heart disease.

Men with severe hair loss may have a higher risk of heart disease.

People with moderate or severe hair loss are at a higher risk of dying from diabetes and heart disease.

Society's pressure to have children later in life favors genes that increase the risk of early baldness in male offspring.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Women with AGA have higher lipid levels, increasing heart disease risk.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

People with androgenetic alopecia may have higher cholesterol and triglycerides, suggesting a higher risk of heart disease.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Oral minoxidil effectively promotes hair growth in men with hair loss, but caution is needed for older or heart-risk patients.

Androgenetic alopecia in young males leads to lower self-esteem, increased anxiety, and higher depression risk.

Men with baldness, ear creases, and hairy ears have a higher risk of heart disease.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.